Active Studies - Cardiology

BI 1245.110
Chronic heart failure with preserved ejection fraction. Phase III

BI 1245.121
Chronic heart failure with reduced ejection fraction. Phase III

DELIVER
Chronic heart failure with preserved ejection fraction. Phase III

Completed Studies - Cardiology

VOYAGER
Risk of thrombotic vascular events. Phase III

AUGUSTUS
Atrial fibrillation and acute coronary syndrome. Phase IV

ATLAS
Acute coronary syndrome. Phase ii

CANTOS
Infarction and vascular inflammation. Phase III

CHARISMA
Antiplatelet cardiovascular prevention. Phase III

CRESCENDO
Cardiovascular risk. Phase III

CSPP
Hypertension. Phase IV

CVT1
Cardiovascular diagnosis. Phase III

CVT2
Ischemic markers. Phase III

DAPA-HF
Chronic heart failure with reduced ejection fraction. Phase III

EUCLID
Peripheral vascular disease. Phase IIIb

GEMINI
Cardiovascular event. Phase III

OASIS
Acute ischemia. Phase III

ODDYSEY
Acute coronary syndrome. Phase IIIb

PARADIGM
Heart failure. Phase III

PEGASUS
Myocardial infarction and secondary prevention. Phase III

STEP-WISE
Heart failure. Phase IIb

THEMIS
Secondary prevention of heart attack. Phase IIIb

Active Studies - Dermatology

There are no active studies at this time

Completed Studies - Dermatology

AP611074 CT4
Genital condyloma. Phase ii

Active Studies - Diabetes

SCORED
Diabetes and kidney failure. Phase III

VERTIS
Diabetes and cardiovascular risk. Phase III

Completed Studies - Diabetes

DAPA CK3
Diabetes and kidney failure. Phase III

DAPA CK4
Diabetes and kidney failure. Phase III

AFICIONADO
Diabetes. Phase IV

ABBVIE
Diabetes and diabetic nephropathy. Phase III

BCB109
Diabetes. Phase III

BC21713
Diabetes. Phase III

BI1218.18
Diabetes. Phase III

BI1245.9
Diabetes. Phase ii

BI1245.10
Diabetes. Phase ii

B1261007
Diabetic nephropathy. Phase III

CACZ
Diabetes. Phase IIb

CLAF 2308
Diabetes. Phase III

CLAF 2310
Diabetes. Phase III

CLAF 2338
Diabetes. Phase III

CLAF 23137
Poorly controlled diabetes with kidney disease. Phase III

CREDENCE
Diabetic nephropathy. Phase III

D1680C0002
Diabetes. Phase IIIb

D1680C0003
Diabetes. Phase IV

DAPA10
Diabetes. Phase IIIb

DECLARE
Diabetes. Phase III

DIA 3008
Diabetes. Phase III

DIA 3011
Diabetes. Phase III

DIA 4003
Diabetes and cardiovascular risk. Phase III

ELIXA
Diabetes and cardiovascular risk. Phase III

EXCSEL
Diabetes and cardiovascular risk. Phase III

FOREST
Diabetes. Phase III

GETGOAL X
Diabetes. Phase III

HARMONY
Diabetes with cardiovascular event. Phase III / IV

IMAGINE 2
Diabetes. Phase III

M11-352
Diabetes and diabetic nephropathy. Phase III

MK-018
Diabetes and cardiovascular risk. Phase III

MK0431-845
Diabetes. Phase III

MK0431-848
Diabetes. Phase III

MK-8835-001
Diabetes and diabetic nephropathy. Phase III

MK-8835-005
Diabetes. Metformin fails. Phase III

NN-95353626
Diabetes. Phase IIIa

ORIGIN
Diabetes and cardiovascular prevention. Phase III

RECAP
Diabetes. Phase III

SAVOR
Diabetes and cardiovascular risk. Phase III

SERENADE
Diabetes. Phase III

TECOS
Diabetes. Phase III

Active Studies - GASTROENTEROLOGY

HIBISCUS I
Ulcerative colitis Phase II / III

HIBISCUS II
Ulcerative colitis Phase III

RLM-MD-02
Diabetic gastroparesis. Phase III

RLM-MD-03
Diabetic gastroparesis. Extension study of the RLM-MD-02. Phase III

RLM-MD-04
Diabetic gastroparesis. Phase III

Completed Studies - GASTROENTEROLOGY

TAKEDA 3030
Ulcerative colitis and Crohn's disease. Phase III

TAKEDA 3031
Ulcerative colitis and Crohn's disease. Phase III

Active Studies - Gynecology

ESTETRA
Hot flushes. Estetrol and placebo

Completed Studies - Gynecology

Active Studies - Nephrology

205270
Anemia associated with chronic kidney disease

AKEBIA 14
Anemia and kidney failure. Phase III

AKEBIA 15
Anemia and kidney failure. Phase III

ASCEND
Anemia and kidney failure. Phase III

Completed Studies - Nephrology

CREDENCE
Anemia and kidney failure. Phase III

OLYMPUS
Anemia and kidney failure. Phase III

PODOCYTE
Focal and segmental glomerulosclerosis. Phase III

DAPA CKD
Chronic kidney failure and proteinuria. Phase III

Active Studies - Pulmonology

208657
COPD characterized by frequent exacerbations and levels of EOSINOPHILS. Phase III

BOREAS
COPD with eosinophilia. Phase III

HZA
Asthma in pediatric patients. Phase III

PEARL
COPD. Phase III

Completed Studies - Pulmonology

201378
Bronchial asthma. Phase III

ACD113874
COPD. Phase III

BORA
Severe bronchial asthma Phase III

CALIMA
Uncontrolled asthma Phase III

CHIESI
COPD. Phase III

CQAB149B2401
COPD. Phase III

CQVA
Moderate to severe COPD. Phase III

CTT
COPD. Phase III

D3250C00018
Uncontrolled asthma Phase III

DYNAGITO
COPD. Phase III

HZA
Asthma in children. Phase III

HZC113782
COPD. Phase II

LABA
Bronchial asthma. Phase III

MEDIVECTOR
Uncomplicated influenza. Phase III

SAS115358
Asthma in children. Phase IIb

SOPHOS
COPD. Phase III

SUMMIT
COPD. Phase III

TERRANOVA
Severe bronchial asthma Phase III

VESTRI
Asthma in children. Phase IV

Active Studies - Osteoporosis

There are no active studies at this time

Completed Studies - Osteoporosis

AMGEM 20110142
Osteoporosis. Phase III

AMGEN 337
Osteoporosis. Phase III

CZOL446M2309
Osteoporosis. Phase III

GHDW
Osteoporosis. Phase IV

RADIUS
Osteoporosis. Phase II

Active Studies - Rheumatology

CONTRAST 1 
Rheumatoid arthritis. Phase III

CONTRAST 3 
Rheumatoid arthritis. Phase III

CONTRAST X 
Contrast 1 and Contrast 3 Extension Study

CREDO 4
Extension of the CREDO 2 and CREDO 3 studies. Phase III

JADY
Rheumatoid arthritis. Phase III

Completed Studies - Rheumatology

OLE
Rheumatoid arthritis. Phase II

CREDO 2
Rheumatoid arthritis for patients with inadequate response to methotrexate. Phase III

ANDES
Rheumatoid arthritis. Phase II

CREDO 3
Rheumatoid arthritis for patients with inadequate response to TNF inhibitors. Phase III

DRIVE
DVT Prophylaxis enti II anti X. Phase II

HIP 1
Hip replacement. Phase III

HIP 2
Hip fracture. Phase III

EFC10571
Knee replacement. Phase III

JADV
Rheumatoid arthritis. Phase III

JADZ
Rheumatoid arthritis. Phase III

Active Studies - Lipids

KOWA
Hypertriglyceridaemia. Phase III

CLEAR
Hypertriglyceridaemia. Phase III

Completed Studies - Lipids

ODDYSEY
Dyslipidemia and acute myocardial infarction. Phase III

Active Studies - THROMBOSIS AND HEMOSTASIA

READY 1.
Phase 3 Clinical Study.
Objective To evaluate the efficacy and safety of CUSA-081 (Reteplase) vs Alteplase vs placebo in the treatment of dysfunction of CVAD (Central Catheters)

Completed Studies - THROMBOSIS AND HEMOSTASIA

ATHENA
Atrial fibrillation Phase III

BOREALIS
Atrial fibrillation Phase III

HOKUSAI
TVP/EP. Phase III

MARINER
Thromboembolic disease. Phase III

ROCKET
Atrial fibrillation Phase III

Active Studies - Neurology

There are no active studies at this time

Completed Studies - Neurology

Active Studies - Oncology

AMEERA-5
Advanced breast cancer. Amcanestrant (SAR439859) plus Plabociclib compared with treatment of ER (+), HER (-) breast cancer patients who have not received any prior systemic antineoplastic therapy for advanced disease.

Completed Studies - Oncology

Active Studies - Infectology

There are no active studies at this time

Completed Studies - Infectology

Open Chat
Centro de Investigaciones Médicas MDP
Thank you for contacting Centro de Investigaciones Médicas, we will be answering you shortly, leave your information so that we can contact you